InnoModels Biotechnology is committed to advancing innovation in biomedical research and clinical therapeutics, and its CDX (Cancer-Derived Xenograft) technology is a leader in the field of cancer modeling. the uniqueness and excellence of CDX technology provides powerful support for cancer research, drug discovery, and personalized therapy.
Introduction to CDX Technology
CDX technology is a cancer tissue-based xenograft technology that creates cancer models by transplanting a patient's cancer tissue into an animal, such as a mouse, to form a human-derived xenograft tumor. The core of this technology is to preserve the heterogeneity and complexity of the original tumor tissue, providing a more realistic and reliable platform for research.
Key advantages of the technology
1. Preservation of original heterogeneity:
By maintaining the heterogeneity of the original cancer tissue, CDX technology enables researchers to gain a more comprehensive understanding of the complex characteristics of tumors. This provides a more accurate data base for precision medicine research.

2. Highly transplantable:
The high portability of CDX transplanted tumors in animals makes it an ideal platform for drug development. Researchers can use this model system to evaluate the effects of different drugs on tumors and accelerate the process of new drug development.
3. Widely used in cancer research:
CDX technology is widely used in the research of various cancer types, covering breast cancer, lung cancer, colorectal cancer, and so on. This provides a common tool for interdisciplinary cancer research and promotes synergistic cooperation between different fields.
Future Prospects
InnoModels Biotechnology is confident about the future of CDX technology. With the continuous development of cancer treatment and research, CDX technology is expected to play a more important role in personalized medicine and targeted therapy. The Company will continue to invest in research and development to continuously improve its technology to meet the constant demands of the research and medical fields.
Conclusion
InnoModels's CDX technology is a leader in the field of cancer modeling, providing scientists and physicians with an advanced and reliable tool. The company is committed to advancing biomedical research forward through continuous innovation and providing more effective treatment options for cancer patients.